Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression

Carcinogenesis

Volumn 21, Issue 8, 2000, Pages 1619-1622

  Tessitore, Luciana ^a,d   Davit, Annalisa ^a   Sarotto, Ivana ^b   Caderni, Giovanna ^c  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Ospedale S Lazzaro   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AZOXYMETHANE; PROTEIN BAX; PROTEIN P21; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; COLON BIOPSY; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; INTESTINE MUCOSA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 0033860505     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.619     Document Type: Article

References (35)

1. Expression of a stilbene synthase gone in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol
2. An anti-platelet principle of veratrum formosarum
3. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity
4. Wine alcohol, platelets and the French paradox for coronary heart disease
5. Inhibition of human LDL oxidation by resveratrol
6. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
7. Differential effects on growth, cell cycle arrest and induction of apoptosis by resveratrol in human prostate cancer cell lines
8. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells
9. Resveratrol, a natural product present in wine, decreases tumor growth in a rat tumor model
10. Colon cancer: A review of the epidemiology
11. Aberrant crypts: Potential preneoplastic lesions in the murine colon
12. Poyethytene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats
13. Fasting/refeeding before initiation enhances the growth of aberrant crypt foci induced by azoxymethane in rat colon and rectum
14. Colon cancer is induced by a single low dose of azoxymethane in fasted/re-fed rats
15. Antioxidant activity of resveratrol in red wine
16. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis
17. A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity
18. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbomyl isothiocyanates
19. Effect of antioxidants, resveratrol, quercitin and N-acetylcysteine. on the function of cultured rat hepatic stellate cells and Kupffer cells
20. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol estertreated human mammary epithelial cells
21. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds
22. Aspirin use and reduced risk of fatal colon cancer
23. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate and 6-phenylhexyl isothiocyanate: Apoptotic index as biomarker in colon cancer chemoprevention and promotion
24. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells
25. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
26. Sequential analysis of the growth and morphological characteristics of aberrant crypt foci: Putative pre-neoplastic lesions
27. Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon
28. Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia
29. p21 (WAFl) is required for butyrate-mediated growth inhibition of human colon cancer cells
30. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
31. Cell-cycle arrest versus cell death in cancer therapy
32. 2 phase transition, Biochem
33. DNA polymerase and topoisomerase II inhibitors from Psoralea coryfolia
34. Resveratrol, a remarkable inhibitor of ribonucleotide reductase